This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Wednesday, April 30, 2014
Watch: The discovery of HCV and why drugs like Gilead’s Sovaldi are the center of an economic debate
Profiles in Innovation:
The Discovery of HCV
Topic Description
Thirty years ago patients who received a blood transfusion had a 30% chance of contracting hepatitis infection, in this video Dr. Harvey Alter, whose research led to the discovery of hepatitis C will discuss his work and the history of HCV.
We also examine how Chiron’s secret six-year effort led to the tests that virtually eliminated the virus from the blood supply, why drugs like Gilead’s Sovaldi are the center of an economic debate on the treatment of HCV, and envision a world in which HCV has been eradicated.
And we talk with Dr. Steven Pearson , who led a health technology assessment of Sovaldi.
Click here to view video
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment